Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin/Mirabegron vs Solifenacin/Estrogen for Detrusor Overactivity
NCT06197295Phase 4Recruiting
- Sponsor
- Mackay Memorial Hospital
- Start
- Jun 2022
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of conjugated estrogens vaginal cream in detrusor overactivity, sponsored by Mackay Memorial Hospital. Started Jun 2022; status: recruiting.
02
Drugs
conjugated estrogens vaginal cream
03
Conditions
detrusor overactivity
Beyond the preview
Go deeper on NCT06197295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06197295.